THAP5
Basic information
Region (hg38): 7:108554543-108569750
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the THAP5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 17 | 18 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 17 | 1 | 0 |
Variants in THAP5
This is a list of pathogenic ClinVar variants found in the THAP5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-108564418-C-G | not specified | Uncertain significance (Jul 20, 2022) | ||
7-108564422-T-A | not specified | Uncertain significance (Nov 08, 2021) | ||
7-108564510-G-A | not specified | Uncertain significance (Dec 05, 2022) | ||
7-108564580-T-G | not specified | Uncertain significance (Dec 09, 2023) | ||
7-108564627-G-A | not specified | Uncertain significance (May 26, 2022) | ||
7-108564663-C-G | not specified | Uncertain significance (Oct 03, 2022) | ||
7-108564663-C-T | not specified | Likely benign (Aug 02, 2021) | ||
7-108564670-A-C | not specified | Uncertain significance (Apr 04, 2024) | ||
7-108564670-A-G | not specified | Uncertain significance (Dec 14, 2022) | ||
7-108564681-G-A | not specified | Uncertain significance (Jun 10, 2022) | ||
7-108564694-T-C | not specified | Uncertain significance (Jun 05, 2024) | ||
7-108564769-T-C | not specified | Uncertain significance (Feb 15, 2023) | ||
7-108564979-C-G | not specified | Uncertain significance (Apr 19, 2024) | ||
7-108564987-A-T | not specified | Uncertain significance (Apr 12, 2022) | ||
7-108564988-C-T | not specified | Uncertain significance (Jun 05, 2023) | ||
7-108565015-C-T | not specified | Uncertain significance (Mar 29, 2022) | ||
7-108565846-A-C | not specified | Uncertain significance (Feb 06, 2023) | ||
7-108565889-T-A | not specified | Uncertain significance (Apr 29, 2024) | ||
7-108565948-T-A | not specified | Uncertain significance (Apr 01, 2024) | ||
7-108566012-G-T | not specified | Uncertain significance (Oct 02, 2023) | ||
7-108569523-C-T | not specified | Uncertain significance (Dec 11, 2023) | ||
7-108569530-G-C | not specified | Uncertain significance (May 31, 2022) | ||
7-108569544-C-T | not specified | Uncertain significance (Dec 18, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
THAP5 | protein_coding | protein_coding | ENST00000415914 | 3 | 15208 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000862 | 0.777 | 125648 | 0 | 50 | 125698 | 0.000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.130 | 183 | 188 | 0.973 | 0.00000839 | 2606 |
Missense in Polyphen | 49 | 53.434 | 0.91702 | 736 | ||
Synonymous | 1.07 | 55 | 66.1 | 0.832 | 0.00000309 | 728 |
Loss of Function | 1.22 | 10 | 15.1 | 0.661 | 7.74e-7 | 205 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000292 | 0.000272 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000381 | 0.000381 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000264 | 0.000264 |
Middle Eastern | 0.000381 | 0.000381 |
South Asian | 0.000196 | 0.000196 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Has sequence-specific DNA-binding activity and can function as transcriptional repressor (in vitro) (PubMed:21110952). May be a regulator of cell cycle: THAP5 overexpression in human cell lines causes cell cycle arrest at G2/M phase (PubMed:19502560). {ECO:0000269|PubMed:21110952, ECO:0000305|PubMed:19502560}.;
Recessive Scores
- pRec
- 0.0998
Intolerance Scores
- loftool
- 0.381
- rvis_EVS
- -0.23
- rvis_percentile_EVS
- 37.11
Haploinsufficiency Scores
- pHI
- 0.0966
- hipred
- N
- hipred_score
- 0.146
- ghis
- 0.636
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.994
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;cell cycle;negative regulation of cell cycle
- Cellular component
- nucleus
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;protease binding;DNA binding;metal ion binding